Skip to main content

Market Overview

UPDATE: JMP Securities Initiates Coverage on Laboratory Corporation of America Awaiting Better Entry Point


In a report published Wednesday, JMP Securities analyst J.T. Haresco initiated coverage on Laboratory Corporation of America (NYSE: LH) with a Market Perform rating.

In the report, JMP Securities noted, “We are initiating coverage on Laboratory Corporation of America with a Market Perform rating. We are supportive of the company's solid progress with its five-pillar strategy to enhance business and return capital to shareholders. Moreover, we believe that the company's lower-cost infrastructure positions it better than its peers for the era of capitated healthcare spending. That said, we believe that the industry headwinds facing LH, including continued concerns with healthcare utilization, reimbursement pressure, and competition, will continue. Hence, we believe shares are fairly valued at current levels and we recommend staying on the sidelines until shares reach a better entry point.”

Laboratory Corporation of America closed on Tuesday at $89.84.

Latest Ratings for LH

Apr 2021Truist SecuritiesMaintainsAbove AverageBuy
Feb 2021MizuhoMaintainsBuy
Feb 2021CitigroupMaintainsBuy

View More Analyst Ratings for LH
View the Latest Analyst Ratings


Related Articles (LH)

View Comments and Join the Discussion!

Posted-In: J.T. Haresco JMP SecuritiesAnalyst Color Initiation Analyst Ratings

Latest Ratings

STXLoop CapitalMaintains100.0
TRVRBC CapitalMaintains163.0
HXLCanaccord GenuityMaintains56.0
NFLXCowen & Co.Maintains650.0
EWCanaccord GenuityMaintains103.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at